Minerva Neurosciences (NERV) Misses Q1 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q1 EPS of ($1.13), $0.12 worse than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• HP shares slide as tech giant forecasts 2027 PC market slump
• Rubico to shift from semi-annual to quarterly financial reporting
• Truist Securities Reiterates Buy Rating on DigitalOcean (DOCN)